1. |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
2. |
Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells——perspectives on current status and future directions:AACR Workshop on cancer stem cells[J]. Cancer Res, 2006, 66(19):9339-9344.
|
3. |
Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice[J]. Nature, 1994, 367(6464):645-648.
|
4. |
Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J]. Nat Med, 1997, 3(7):730-737.
|
5. |
Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci USA, 2003, 100(7):3983-3988.
|
6. |
Liu G, Yuan X, Zeng Z, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma[J]. Mol Cancer, 2006, 5:67.
|
7. |
Vaiopoulos AG, Kostakis ID, Koutsilieris M, et al. Colorectal cancer stem cells[J]. Stem Cells, 2012, 30(3):363-371.
|
8. |
Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer[J]. Cell Stem Cell, 2007, 1(3):313-323.
|
9. |
Casagrande F, Cocco E, Bellone S, et al. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin[J]. Cancer, 2011, 117(24):5519-5528.
|
10. |
Garcia-Gomez I, Elvira G, Zapata AG, et al. Mesenchymal stem cells:biological properties and clinical applications[J]. Expert Opin Biol Ther, 2010, 10(10):1453-1468.
|
11. |
Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system[J]. Science, 1992, 255(552):1707-1710.
|
12. |
Lansdorp PM, Dragowska W. Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow[J]. J Exp Med, 1992, 175(6):1501-1509.
|
13. |
Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells[J]. Proc Natl Acad Sci USA, 2004, 101(39):14228-14233.
|
14. |
Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties[J]. Hepatology, 2006, 44(1):240-251.
|
15. |
Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness[J]. Proc Natl Acad Sci USA, 2006, 103(30):11154-11159.
|
16. |
Haraguchi N, Utsunomiya T, Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system[J]. Stem Cells, 2006, 24(3):506-513.
|
17. |
Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma[J]. Proc Natl Acad Sci USA, 2007, 104(3):973-978.
|
18. |
Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J]. Cell Stem Cell, 2007, 1(5):555-567.
|
19. |
Beier D, Hau P, Proescholdt M, et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles[J]. Cancer Res, 2007, 67(9):4010-4015.
|
20. |
Liu SY, Zheng PS. High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer[J]. Oncotarget, 2013, 4(12):2462-2475.
|
21. |
Pang R, Law WL, Chu AC, et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer[J]. Cell Stem Cell, 2010, 6(6):603-615.
|
22. |
Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells[J]. Cancer Res, 2007, 67(3):1030-1037.
|
23. |
Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells[J]. Cancer Res, 2005, 65(23):10946-10951.
|
24. |
Richardson GD, Robson CN, Lang SH, et al. CD133, a novel marker for human prostatic epithelial stem cells[J]. J Cell Sci, 2004, 117 (Pt 16):3539-3545.
|
25. |
Dean M, Fojo T, Bates S. Tumor stem cells and drug resistance[J]. Nat Rev Cancer, 2005, 5(4):275-284.
|
26. |
Singh A, Settleman J. EMT, cancer stem cells and drug resistance:an emerging axis of evil in the war on cancer[J]. Oncogene, 2010, 29(34):4741-4751.
|
27. |
Hu X, Ghisolfi L, Keates AC, et al. Induction of cancer cell stemness by chemotherapy[J]. Cell Cycle, 2012, 11(14):2691-2698.
|
28. |
谢玲玲, 卢淮武, 钟沅月, 等.分割剂量射线照射富集宫颈癌肿瘤干细胞的研究[J]. 中山大学学报:医学科学版, 2012, 33(3):330-335.
|
29. |
路秀英, 李晓明. 低氧诱导因子对肿瘤干细胞作用的研究进展[J]. 医学综述, 2008(20):3081-3083.
|
30. |
Bhaskara VK, Mohanam I, Rao JS, et al. Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells[J]. PLoS One, 2012, 7(2):e309D5.
|
31. |
Radisky DC. Epithelial-mesenchymal transition[J]. J Cell Sci, 2005, 118(19):4325-4326.
|
32. |
Santisteban M, Reiman JM, Asiedu MK, et al. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells[J]. Cancer Res, 2009, 69(7):2887-2895.
|
33. |
Ye J, Wu D, Shen J, et al. Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown[J]. Mol Med Rep, 2012, 6(3):507-512.
|
34. |
Li J, Zhou BP. Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem celllike characters[J]. BMC Cancer, 2011, 11:49.
|
35. |
Jin L, Hope KJ, Zhai Q, et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells[J]. Nat Med, 2006, 12(10):1167-1174.
|
36. |
Gadhoum Z, Delaunay J, Maquarre E, et al. The effect of antiCD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells[J]. Leuk Lymphoma, 2004, 45(8):1501-1510.
|
37. |
Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis[J]. Nature, 2004, 432(715):324-331.
|
38. |
Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML[J]. N Engl J Med, 2004, 351(7):657-667.
|
39. |
Mamaeva V, Rosenholm JM, Bate-Eya LT, et al. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer[J]. Mol Ther, 2011, 19(8):1538-1546.
|
40. |
Clement V, Sanchez P, De Tribolet N, et al. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell selfrenewal, and tumorigenicity[J]. Curr Biol, 2007, 17(2):165-172.
|
41. |
Zhou Y, Yang J, Kopeček J. Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells[J]. Biomaterials, 2012, 33(6):1863-1872.
|